Почетна › Колоректален карцином › Колорадо
Клинички испитувања за Колоректален карцином во Колорадо
56 студии за Колоректален карцином бараат учесници на локации во Колорадо.
Градови во Колорадо
- Aurora32 студии
- Denver23 студии
- Centennial9 студии
- Highlands Ranch8 студии
- Colorado Springs6 студии
- Lakewood5 студии
- Pueblo5 студии
- Longmont5 студии
- Boulder4 студии
- Westminster4 студии
- Loveland3 студии
- Greeley3 студии
- Thornton3 студии
Официјален текст на студијата (англиски)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Keefe Memorial Hospital, Cheyenne Wells
- Kaiser Permanente-Franklin, Denver
- Poudre Valley Hospital, Fort Collins
- и уште 5
Се регрутираДобредојдени се здрави волонтери
Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Rocky Mountain Cancer Centers - Aurora /ID# 280112, Aurora
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07525206Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- University of Colorado, Aurora
Се регрутира
Возраст од 65 до 82 · Сите полови · Ажурирано 2.10.2026 · NCT05612347Family Communications After Genetic Testing
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
- и уште 6
Се регрутираДобредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07143487The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Rocky Mountain Cancer Center, Denver
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
- Penrose-Saint Francis Healthcare, Colorado Springs
- и уште 15
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #87, Littleton
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT05176483Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Rocky Mountain Cancer Centers, LLP, Aurora
- Rocky Mountain Cancer Centers - Boulder, Boulder
- Rocky Mountain Cancer Centers, LLP, Centennial
- и уште 18
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07222800Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Sarah Cannon Research Institute (SCRI), Denver
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05482893A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- University of Colorado Anschutz Medical Campus ( Site 0299), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0325), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0326), Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06428409A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- University of Colorado Denver Anschultz Medical Campus, Aurora
- Rocky Mountain Cancer Centers, Denver
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06750094A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- University of Colorado Denver Anschultz Medical Campus, Aurora
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06663319A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Rocky Mountain Cancer Centers, Denver
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06662786Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- UCHealth University of Colorado Hospital, Aurora
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT05863195Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- UCHealth University of Colorado Hospital, Aurora
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT06102902Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- University of Colorado Hospital-Anschutz Cancer Pavilion, Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Colorado Cancer Center, Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- University of Colorado - Aurora Cancer Center, Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT05786924A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- GSK Investigational Site, Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07213609A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Sarah Cannon Research Institute Scri Oncology Partners, Aurora
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT07284849A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- University of Colorado Cancer Center, Aurora
- Rocky Mountain Cancer Centers, LLP, Lone Tree
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT04929223Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
- UCHealth University of Colorado Hospital, Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07147231A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Rocky Mountain Cancer Centers, LLP- Aurora, Lone Tree
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07549412A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- University of Colorado, Aurora
Се регрутираФаза 1
Возраст од 18 до 99 · Сите полови · Ажурирано 1.9.2026 · NCT06983743A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- SCRI at HCA Health One, Denver
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 27.8.2026 · NCT07186842A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- SCRI Denver, Denver
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 27.8.2026 · NCT07227168Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Colorado, Aurora
Се регрутираФаза 1/2
12 Months – 30 Years · Сите полови · Ажурирано 25.8.2026 · NCT04851119MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- Sarah Cannon Research Institute at HealthOne, Denver
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 24.8.2026 · NCT06586515Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- University of Colorado Denver, Aurora
- UCHealth Highlands Ranch Hospital, Highlands Ranch
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 18 до 99 · Сите полови · Ажурирано 24.8.2026 · NCT05517811A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
- University of Colorado Hospital- Anschutz Cancer Center Pavillion (ACP), Aurora
- University of Colorado Cancer Center - Highlands Ranch Hospital, Highlands Ranch
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT07235293Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- University of Colorado Anschutz Medical Center, Aurora
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT05410977FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Colorado, Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05919264Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
- University of Colorado Hospital, Aurora
Се регрутираДобредојдени се здрави волонтери
Возраст од 18 до 85 · Сите полови · Ажурирано 14.8.2026 · NCT07759921A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- University of Colorado, Aurora
- Sarah Cannon Research Institute, Denver
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 13.8.2026 · NCT07066657A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, Aurora
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 3.8.2026 · NCT06885034A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Rocky Mountain Cancer Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Rocky Mountain Cancer Centers, Lone Tree
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 29.7.2026 · NCT03526835A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Sarah Cannon Research Institue At Healthone, Denver
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT06179160A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Rocky Mountain Cancer Centers, LLP, Aurora
- Rocky Mountain Cancer Centers, LLP, Boulder
- Rocky Mountain Cancer Centers, LLP, Colorado Springs
- и уште 8
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT05253651A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT06131840Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.